Trial site
University of California Davis Health
- 10running trials
- 5closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease2 trials
- Osteoarthritis2 trials
- Autism1 trial
- COPD1 trial
- Cystic fibrosis1 trial
- Dilated cardiomyopathy1 trial
- Haemophilia1 trial
- Hypertrophic cardiomyopathy1 trial
- Long COVID and ME/CFS1 trial
- Multiple sclerosis1 trial
- Neuromyelitis optica (NMOSD)1 trial
- Primary biliary cholangitis1 trial
- and 2 more
- Phase
- Phase 34 trials
- Phase 1/22 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Completed5 trials
- Recruiting5 trials
- Active, not recruiting4 trials
- Not yet recruiting1 trial
- Lead sponsor
- University of California, Davis5 trials
- Bristol-Myers Squibb2 trials
- Ad scientiam1 trial
- BioMarin Pharmaceutical1 trial
- COUR Pharmaceutical Development Company, Inc.1 trial
- and 5 more
Running trials
Active, not recruiting
Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial
Recruiting
Recruiting
The Effects of Patient and Visit Characteristics on Health Outcomes in Knee Osteoarthritis
Active, not recruiting
Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients
Recruiting
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
Recruiting
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
Recruiting
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
Recruiting
Active, not recruiting
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- Multiple sclerosis1 recruiting
- Neuromyelitis optica (NMOSD)1 recruiting
- Osteoarthritis1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial
Site data: ClinicalTrials.govUpdated 17 Nov 2026